Moreover, in our study, P-selectin was revealed to be an optimal and stable biomarker of endothelial dysfunction and platelet activity, demonstrating a consistent pattern for predicting disease severity among patients with different clinical characteristics, such as in the Delta and Omicron variants, compared with other coagulation biomarkers. Here, SELP is linked to endothelial dysfunction.